Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Oct-22 5:06 PM View:  | Sandler Andrew Seth Director | Dermata Therapeutics, Inc. (DRMA) | 06-Oct-22 | Grant | 10,120 | -- | -- | 72% 14.06K to 24.18K | |
| 07-Oct-22 5:05 PM View: | Scott Kathleen D. Director | Dermata Therapeutics, Inc. (DRMA) | 06-Oct-22 | Grant | 11,359 | -- | -- | 62% 18.23K to 29.58K | |
| 07-Oct-22 5:06 PM View: | Hale David F Director | Dermata Therapeutics, Inc. (DRMA) | 06-Oct-22 | Grant | 30,155 | -- | -- | 5% 626.4K to 656.55K | |
| 07-Oct-22 5:06 PM View: | Bradrick Brittany Director | Dermata Therapeutics, Inc. (DRMA) | 06-Oct-22 | Grant | 9,810 | -- | -- | 72% 13.63K to 23.44K | |
| 07-Oct-22 5:05 PM View: | Wierenga Wendell Director | Dermata Therapeutics, Inc. (DRMA) | 06-Oct-22 | Grant | 20,654 | -- | -- | 49% 41.74K to 62.4K | |
| 07-Oct-22 5:05 PM View: | Fisher Mary Director | Dermata Therapeutics, Inc. (DRMA) | 06-Oct-22 | Grant | 9,810 | -- | -- | 72% 13.63K to 23.44K | |
| 08-Jul-22 4:10 PM View: | Scott Kathleen D. Director | Dermata Therapeutics, Inc. (DRMA) | 07-Jul-22 | Grant | 9,960 | -- | -- | 121% 8.27K to 18.23K | |
| 08-Jul-22 4:10 PM View: | Hale David F Director | Dermata Therapeutics, Inc. (DRMA) | 07-Jul-22 | Grant | 26,441 | -- | -- | 9% 285.95K to 312.39K | |
| 08-Jul-22 4:10 PM View: | Bradrick Brittany Director | Dermata Therapeutics, Inc. (DRMA) | 07-Jul-22 | Grant | 8,602 | -- | -- | 171% 5.03K to 13.63K | |
| 08-Jul-22 4:10 PM View: | Wierenga Wendell Director | Dermata Therapeutics, Inc. (DRMA) | 07-Jul-22 | Grant | 18,110 | -- | -- | 77% 23.63K to 41.74K | |
| 08-Jul-22 4:10 PM View: | Fisher Mary Director | Dermata Therapeutics, Inc. (DRMA) | 07-Jul-22 | Grant | 8,602 | -- | -- | 171% 5.03K to 13.63K | |
| 08-Jul-22 4:10 PM View: | Sandler Andrew Seth Director | Dermata Therapeutics, Inc. (DRMA) | 07-Jul-22 | Grant | 8,874 | -- | -- | 171% 5.19K to 14.06K | |
| 08-Apr-22 7:19 PM View: | Fisher Mary Director | Dermata Therapeutics, Inc. (DRMA) | 07-Apr-22 | Grant | 5,031 | -- | -- | 100% 0 to 5.03K | |
| 08-Apr-22 7:15 PM View: | Sandler Andrew Seth Director | Dermata Therapeutics, Inc. (DRMA) | 07-Apr-22 | Grant | 5,190 | -- | -- | 100% 0 to 5.19K | |
| 08-Apr-22 7:17 PM View: | Scott Kathleen D. Director | Dermata Therapeutics, Inc. (DRMA) | 07-Apr-22 | Grant | 5,826 | -- | -- | 239% 2.44K to 8.27K | |
| 08-Apr-22 7:12 PM View: | Hale David F Director | Dermata Therapeutics, Inc. (DRMA) | 07-Apr-22 | Grant | 15,466 | -- | -- | 6% 270.49K to 285.95K | |
| 08-Apr-22 7:13 PM View: | Bradrick Brittany Director | Dermata Therapeutics, Inc. (DRMA) | 07-Apr-22 | Grant | 5,031 | -- | -- | 100% 0 to 5.03K | |
| 08-Apr-22 7:26 PM View: | Wierenga Wendell Director | Dermata Therapeutics, Inc. (DRMA) | 07-Apr-22 | Grant | 10,593 | -- | -- | 217% 4.88K to 15.47K | |
| 26-Nov-21 1:30 PM View: | Proehl Gerald T President, CEO and Chairman Director 10% Owner | Dermata Therapeutics, Inc. (DRMA) | 23-Nov-21 | Market Purchase | 20,000 | $2.40 | $48,000.00 | < 1% 3.16M to 3.18M | 17% |
| 17-Aug-21 12:49 PM View: | Hale David F Director 10% Owner | Dermata Therapeutics, Inc. (DRMA) | 17-Aug-21 | Conversion | 278,291 | -- | -- | 103% 270.49K to 548.78K | |
| 17-Aug-21 12:39 PM View: | Nardo Christopher J. Senior VP, Development | Dermata Therapeutics, Inc. (DRMA) | 17-Aug-21 | Conversion | 2,439 | -- | -- | 10% 25.12K to 27.56K | |
| 17-Aug-21 12:48 PM View: | Proehl Investment Ventures ... 10% Owner | Dermata Therapeutics, Inc. (DRMA) | 17-Aug-21 | Conversion | 1,988,230 | -- | -- | 217% 917.31K to 2.91M | |
| 17-Aug-21 12:49 PM View: | Hale David F Director 10% Owner | Dermata Therapeutics, Inc. (DRMA) | 17-Aug-21 | Purchase | 35,714 | -- | -- | 7% 548.78K to 584.49K | |
| 17-Aug-21 12:38 PM View: | Proehl Gerald T President, CEO and Chairman Director 10% Owner | Dermata Therapeutics, Inc. (DRMA) | 17-Aug-21 | Purchase | 142,857 | -- | -- | 5% 3.02M to 3.16M | |
| 17-Aug-21 12:40 PM View: | Insley Thomas Chief Financial Officer | Dermata Therapeutics, Inc. (DRMA) | 17-Aug-21 | Conversion | 4,581 | -- | -- | 47% 9.76K to 14.34K | |
| 17-Aug-21 12:51 PM View: | Bedoya-Toro Maria E Senior Vice President | Dermata Therapeutics, Inc. (DRMA) | 17-Aug-21 | Conversion | 64,631 | -- | -- | 129% 50.0K to 114.63K | |
| 17-Aug-21 12:38 PM View: | Proehl Gerald T President, CEO and Chairman Director 10% Owner | Dermata Therapeutics, Inc. (DRMA) | 17-Aug-21 | Conversion | 2,050,780 | -- | -- | 212% 966.83K to 3.02M | |
| 17-Aug-21 12:45 PM View: | Wierenga Wendell Director | Dermata Therapeutics, Inc. (DRMA) | 17-Aug-21 | Conversion | 8,163 | -- | -- | 167% 4.88K to 13.04K | |
| 17-Aug-21 12:38 PM View: | Proehl Gerald T President, CEO and Chairman Director 10% Owner | Dermata Therapeutics, Inc. (DRMA) | 16-Aug-21 | Purchase | 10,000 | $4.96 | $49,631.00 | 1% 956.83K to 966.83K |
